Circulating miR-34a levels are reduced in colorectal cancer
- PMID: 22648208
- DOI: 10.1002/jso.23174
Circulating miR-34a levels are reduced in colorectal cancer
Abstract
Introduction: MicroRNAs (miRNAs) are small, non-coding RNA segments that regulate gene expression via post-transcriptional inhibition and have roles in cell differentiation, proliferation, and apoptosis. Expression differs between tumor and normal tissue in several malignancies. Most work has focused on tissue and cell expression with few reports of circulating miRNAs in colorectal cancer. Available biomarkers for colorectal cancer have limited sensitivity and specificity, thus there is a need for new markers.
Aims: This study aimed to identify miRNAs that are differentially expressed in the blood of colorectal cancer patients compared to controls and to establish if this is specific to colorectal cancer and thus could be utilized as potential tumor markers.
Methods: Blood samples were collected from 63 colorectal cancer patients and 45 controls. Expression of 7 target miRNAs (miR-143, miR-145, miR-21, miR-30a-3p, miR-31, miR-34a, and miR-92) was measured using RQ-PCR. Results were correlated with clinicopathological data and analyzed. Analysis of differentially expressed circulating miRNAs was expanded to include 62 patients with prostate, renal, breast, and melanoma cancers.
Results: Analysis of the relative quantification of the target miRNAs showed significantly reduced expression (P = 0.004) of miR-34a in colorectal cancer. MiR-34a was also significantly reduced in breast cancer (P = 0.019).
Conclusion: This study demonstrates significantly reduced expression of circulating miR-34a in colorectal and breast cancer. This may have future application as part of a biomarker profile.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
-
Plasma miR-21: a potential diagnostic marker of colorectal cancer.Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f. Ann Surg. 2012. PMID: 22868372
-
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.Ann Hematol. 2012 Apr;91(4):553-9. doi: 10.1007/s00277-011-1350-9. Epub 2011 Oct 11. Ann Hematol. 2012. PMID: 21987025
-
Prognostic implications of serum microRNA-21 in colorectal cancer.J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23. J Surg Oncol. 2013. PMID: 23970420
-
MicroRNA signatures: novel biomarker for colorectal cancer?Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21551242 Review.
-
MicroRNAs are novel biomarkers of colorectal cancer.Br J Surg. 2009 Jul;96(7):702-10. doi: 10.1002/bjs.6628. Br J Surg. 2009. PMID: 19526617 Review.
Cited by
-
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.BMC Cancer. 2015 Apr 30;15:329. doi: 10.1186/s12885-015-1327-5. BMC Cancer. 2015. PMID: 25924769 Free PMC article.
-
The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23177-23187. doi: 10.18632/oncotarget.15520. Oncotarget. 2017. PMID: 28423566 Free PMC article. Review.
-
Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.Med Sci Monit. 2017 Dec 3;23:5735-5743. doi: 10.12659/msm.904937. Med Sci Monit. 2017. PMID: 29197895 Free PMC article.
-
The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.PLoS One. 2013 Jun 28;8(6):e66842. doi: 10.1371/journal.pone.0066842. Print 2013. PLoS One. 2013. PMID: 23840538 Free PMC article.
-
KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.Mol Oncol. 2016 Aug;10(7):993-1007. doi: 10.1016/j.molonc.2016.03.008. Epub 2016 Apr 8. Mol Oncol. 2016. PMID: 27093921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical